On the other hand, CD44-positive populations (CD24+/CD44+ and CD24−/CD44+) exhibited sustained or enhanced proliferative potential during the recovery phase, highlighting the association between CD44 and cancer stem cell-like traits, including enhanced survival, self-renewal, and therapeutic resistance. This evidence concerns the gene CD24 and cancer.